Management of pulmonary hypertension in the operating room (Q36834626)

16 August 2017

1 reference

title

Management of pulmonary hypertension in the operating room (English)

1 reference

16 August 2017

pulmonary hypertension

1 reference

based on heuristic

inferred from title

author name string

Kathirvel Subramaniam

series ordinal

1

1 reference

16 August 2017

Jean-Pierre Yared

series ordinal

2

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 June 2007

1 reference

Seminars in Cardiothoracic and Vascular Anesthesia

16 August 2017

1 reference

16 August 2017

11

1 reference

16 August 2017

119-136

1 reference

16 August 2017

2

1 reference

Sympathetic modulation of hypoxic pulmonary vasoconstriction in intact dogs.

16 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Successful weaning from cardiopulmonary bypass with central venous prostaglandin E1 and left atrial norepinephrine infusion in patients with acute pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Effect of prostaglandin E1 on pulmonary hypertension after protamine injection during cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Use of prostaglandin E1 to treat peri-anaesthetic pulmonary hypertension associated with mitral valve disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Efficiency of prostacyclin in the treatment of protamine-mediated right ventricular failure and acute pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Response to nitric oxide during adult cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Response to inhaled nitric oxide in patients with acute right heart syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Dose response to nitric oxide in adult cardiac surgery patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

A comparison of inhaled nitric oxide and milrinone for the treatment of pulmonary hypertension in adult cardiac surgery patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Inhaled nitric oxide in patients with normal and increased pulmonary vascular resistance after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Inhaled nitric oxide improves hemodynamics in patients with acute pulmonary hypertension after high-risk cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Inhaled nitric oxide administration during one-lung ventilation in patients undergoing thoracic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Intraoperative inhaled nitric oxide during anesthesia for lung transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Inhaled nitric oxide reduces pulmonary vascular resistance more than prostaglandin E(1) during heart transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Inhaled iloprost controls pulmonary hypertension after cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Intraoperative inhalation of the long-acting prostacyclin analog iloprost for pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Inhaled prostacyclin (PGI2) is an effective addition to the treatment of pulmonary hypertension and hypoxia in the operating room and intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Inhaled areosolized prostacyclin and pulmonary hypertension during anesthesia for lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Inhaled prostacyclin for the treatment of pulmonary hypertension after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Cardiopulmonary effects of aerosolized prostaglandin E1 and nitric oxide inhalation in patients with acute respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Retrospective evaluation of inhaled prostaglandins in patients with acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Endotracheal inhalatory sodium nitroprusside in severely hypoxic newborns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Inhaled but not intravenous milrinone prevents pulmonary endothelial dysfunction after cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Milrinone and nitric oxide: combined effect on pulmonary artery pressures after cardiopulmonary bypass in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Phosphodiesterase-3 inhibition prevents the increase in pulmonary vascular resistance following inhaled nitric oxide withdrawal in lambs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Adenosine effectively controls pulmonary hypertension after cardiac operations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Dipyridamole potentiates pulmonary vasodilation induced by acetylcholine and nitric oxide in the ovine fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Sildenafil for pulmonary hypertension after heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Sildenafil can increase the response to inhaled nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Selective pulmonary vasodilation induced by aerosolized zaprinast.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

High-risk mitral valve surgery: perioperative hemodynamic optimization with nesiritide (BNP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Pulmonary vasodilation by nitric oxide gas and prodrug aerosols in acute pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Hemodynamic and oxygenation changes of combined therapy with inhaled nitric oxide and inhaled aerosolized prostacyclin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Pulmonary vascular effects of propofol at baseline, during elevated vasomotor tone, and in response to sympathetic alpha- and beta-adrenoreceptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Hypoxia-induced vasoconstriction in isolated perfused lungs exposed to injectable or inhalation anesthetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Responses to propofol in the pulmonary vascular bed of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Hemodynamic responses to etomidate on induction of anesthesia in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Comparison of the effects of isoflurane with those of propofol on pulmonary vascular impedance in experimental embolic pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Cardiovascular effects of sevoflurane compared with those of isoflurane in volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Sevoflurane versus isoflurane in patients undergoing valvular cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Sevoflurane versus isoflurane in patients undergoing coronary artery bypass grafting: a hemodynamic and recovery study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Cardiopulmonary effects of enoximone or dobutamine and nitroglycerin on mitral valve regurgitation and pulmonary venous hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

The effect of phenylephrine and norepinephrine in patients with chronic pulmonary hypertension*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Effect of dopamine vs norepinephrine on hemodynamics in septic shock. Emphasis on right ventricular performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Effects of vasopressin on right ventricular function in an experimental model of acute pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Vasopressin during spinal anesthesia in a patient with primary pulmonary hypertension treated with intravenous epoprostenol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Anesthetic considerations for parturients with primary pulmonary hypertension: review of the literature and clinical presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Thoracic epidural anaesthesia and primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Epidural anaesthesia and pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

The evolving management of acute right-sided heart failure in cardiac transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Right ventricular function in an operating room model of mechanical left ventricular assistance and its effects in patients with depressed left ventricular function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Oxidation-specific epitopes in human coronary atherosclerosis are not limited to oxidized low-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Risk quantification of early outcome after lung transplantation: donor, recipient, operative, and post-transplant parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Respiratory failure after lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Protamine and protamine reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Effect of site of venous protamine administration, previously alleged risk factors, and preoperative use of aspirin on acute protamine-induced pulmonary vasoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Effects of a thromboxane receptor antagonist (NT-126) and a thromboxane synthase inhibitor (OKY-O46) on protamine-induced circulatory changes in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

The use of nitric oxide for managing catastrophic pulmonary vasoconstriction arising from protamine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Pulmonary artery rupture induced by a pulmonary artery catheter: a case report and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

Randomized, Double-Blind Trial of Inhaled Nitric Oxide in LVAD Recipients With Pulmonary Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1089253207301733

21 January 2018

Identifiers

DOI

10.1177/1089253207301733

0 references

1 reference